{"id":1121,"date":"2026-03-31T20:19:58","date_gmt":"2026-03-31T18:19:58","guid":{"rendered":"https:\/\/epilogy.org\/?p=1121"},"modified":"2026-04-01T16:04:07","modified_gmt":"2026-04-01T14:04:07","slug":"epilogy-formerly-epiderme-labeled-by-inserm","status":"publish","type":"post","link":"https:\/\/epilogy.org\/fr\/epilogy-formerly-epiderme-labeled-by-inserm","title":{"rendered":"Epilogy (anciennement EpiDermE) labellis\u00e9e Inserm"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"1121\" class=\"elementor elementor-1121\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9007e99 e-flex e-con-boxed e-con e-parent\" data-id=\"9007e99\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0ac69e5 elementor-widget elementor-widget-html\" data-id=\"0ac69e5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<style>\n.epilogy-news{\nbackground:#ffffff;\nborder:1px solid #ead3ee;\nborder-radius:8px;\npadding:22px;\nmargin:24px 0;\nfont-size:13px;\ncolor:#54595F;\nline-height:1.7;\nbox-shadow:0 2px 8px rgba(0,0,0,0.04);\n}\n\n.epilogy-news-badge{\ndisplay:inline-block;\nmargin-bottom:12px;\npadding:4px 10px;\nborder-radius:20px;\nbackground:#FADFFF;\ncolor:#7C2A86;\nfont-size:12px;\nfont-weight:600;\n}\n\n.epilogy-news h2{\nmargin:0 0 14px 0;\ncolor:#7C2A86;\nfont-size:20px;\nline-height:1.3;\n}\n\n.epilogy-news p{\nmargin:0 0 12px 0;\n}\n\n.epilogy-news-highlight{\nbackground:#FADFFF;\nborder-left:4px solid #7C2A86;\nborder-radius:6px;\npadding:14px;\nmargin:18px 0;\n}\n\n.epilogy-news-highlight strong{\ncolor:#7C2A86;\n}\n\n.epilogy-news-footer{\nmargin-top:16px;\npadding-top:14px;\nborder-top:1px solid #eee;\nfont-size:12px;\ncolor:#777;\ntext-align:center;\n}\n<\/style>\n\n<div class=\"epilogy-news\">\n\n<div class=\"epilogy-news-badge\">Labellisation Inserm<\/div>\n\n<h2>Epilogy obtient la labellisation Inserm<\/h2>\n\n<p>\nL\u2019\u00e9quipe Epilogy \u2013 Epidemiology and Evaluation of Therapeutics in Dermatology and Immune-Mediated Inflammatory Diseases, bas\u00e9e \u00e0 la Facult\u00e9 de Sant\u00e9 de l\u2019H\u00f4pital Universitaire Henri-Mondor \u00e0 Cr\u00e9teil, s\u2019inscrit aujourd\u2019hui comme un acteur majeur de la recherche en dermatologie et maladies inflammatoires immuno-m\u00e9di\u00e9es. Anciennement connue sous le nom d\u2019EpiDermE, l\u2019\u00e9quipe a progressivement structur\u00e9 un programme scientifique ambitieux centr\u00e9 sur l\u2019\u00e9pid\u00e9miologie clinique, l\u2019\u00e9valuation des strat\u00e9gies th\u00e9rapeutiques et l\u2019analyse critique des preuves scientifiques en dermatologie.\n<\/p>\n\n<p>\nInt\u00e9gr\u00e9e \u00e0 l\u2019Institut Mondor au sein de l\u2019unit\u00e9 U955 de l\u2019Inserm, l\u2019\u00e9quipe Epilogy a obtenu en janvier sa labellisation Inserm, marquant une \u00e9tape structurante dans son d\u00e9veloppement. Cette reconnaissance institutionnelle atteste de la qualit\u00e9 scientifique de ses travaux, de la coh\u00e9rence de sa strat\u00e9gie de recherche et de son rayonnement dans le domaine des dermatoses chroniques et des maladies inflammatoires immuno-m\u00e9di\u00e9es.\n<\/p>\n\n<div class=\"epilogy-news-highlight\">\n<strong>La labellisation Inserm marque une \u00e9tape majeure<\/strong> dans le d\u00e9veloppement d\u2019Epilogy et confirme la qualit\u00e9 scientifique de sa strat\u00e9gie de recherche ainsi que son r\u00f4le croissant en dermatologie et dans les maladies inflammatoires \u00e0 m\u00e9diation immunitaire.\n<\/div>\n\n<p>\nCette labellisation s\u2019appuie sur une organisation r\u00e9solument multidisciplinaire, r\u00e9unissant dermatologues, \u00e9pid\u00e9miologistes, biostatisticiens et m\u00e9thodologistes autour d\u2019objectifs communs. Cette diversit\u00e9 de comp\u00e9tences favorise une approche int\u00e9gr\u00e9e de l\u2019\u00e9valuation des traitements, de l\u2019identification des effets ind\u00e9sirables et de l\u2019am\u00e9lioration des m\u00e9thodologies en recherche clinique et en synth\u00e8se des preuves.\n<\/p>\n\n<p>\nL\u2019\u00e9quipe Epilogy se distingue \u00e9galement par sa coh\u00e9sion et son dynamisme, reposant sur une forte implication collective dans les projets scientifiques et le d\u00e9veloppement de nouvelles collaborations. L\u2019int\u00e9gration de nombreux doctorants et jeunes chercheurs constitue un axe structurant, contribuant \u00e0 renforcer la production scientifique de l\u2019\u00e9quipe tout en assurant la formation d\u2019une nouvelle g\u00e9n\u00e9ration de sp\u00e9cialistes en dermatologie et en \u00e9pid\u00e9miologie clinique.\n<\/p>\n\n<p>\nImplant\u00e9e \u00e0 Cr\u00e9teil, au c\u0153ur d\u2019un environnement hospitalo-universitaire reconnu, l\u2019\u00e9quipe Epilogy b\u00e9n\u00e9ficie ainsi d\u2019un \u00e9cosyst\u00e8me propice aux projets collaboratifs \u00e0 fort impact. L\u2019obtention de cette labellisation confirme son r\u00f4le dans l\u2019avanc\u00e9e des connaissances en dermatologie et dans l\u2019\u00e9valuation des strat\u00e9gies th\u00e9rapeutiques pour les patients atteints de maladies inflammatoires immuno-m\u00e9di\u00e9es.\n<\/p>\n\n<div class=\"epilogy-news-footer\">\nEpilogy \u2013 \u00c9pid\u00e9miologie et \u00e9valuation des th\u00e9rapeutiques en dermatologie et dans les maladies inflammatoires \u00e0 m\u00e9diation immunitaire\n<\/div>\n\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Inserm accreditation Epilogy receives Inserm accreditation The Epilogy \u2013 Epidemiology and Evaluation of Therapeutics in Dermatology and Immune-Mediated Inflammatory Diseases group, based at the Faculty of Health of Henri-Mondor University Hospital in Cr\u00e9teil, is now recognized as a major contributor to research in dermatology and immune-mediated inflammatory diseases. Formerly known as EpiDermE, the group has&hellip;&nbsp;<a href=\"https:\/\/epilogy.org\/fr\/epilogy-formerly-epiderme-labeled-by-inserm\" rel=\"bookmark\"><span class=\"screen-reader-text\">Epilogy (anciennement EpiDermE) labellis\u00e9e Inserm<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":1057,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","neve_meta_reading_time":"","footnotes":""},"categories":[19,1,18],"tags":[],"class_list":["post-1121","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-epifocus","category-epilogy","category-epinews"],"_links":{"self":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts\/1121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/comments?post=1121"}],"version-history":[{"count":4,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts\/1121\/revisions"}],"predecessor-version":[{"id":1178,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts\/1121\/revisions\/1178"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/media\/1057"}],"wp:attachment":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/media?parent=1121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/categories?post=1121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/tags?post=1121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}